Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Adolfsson

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Journal of Diabetes Science and Technology|April 28, 2016
Impact of Type 1 Diabetes Technology on Family Members/Significant Others of People With DiabetesKatharine Barnard, Vincent Crabtree, Peter Adolfsson, et al.
Diabetes Technology & Therapeutics|January 9, 2019
Use of Continuous Glucose Monitoring Trends to Facilitate Exercise in Children with Type 1 DiabetesMarie-Anne Burckhardt, Tarini Chetty, Grant J Smith, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 14, 2025
Insights into the effective use of the Smart MDI system: Data from the first 1852 type 1 diabetes usersAndrea Laurenzi, Shannon N Edd, Peter Adolfsson, et al.
Diabetes, Obesity & Metabolism|December 27, 2024
Minimum expectations for market authorization of continuous glucose monitoring devices in Europe-'eCGM' compliance statusChantal Mathieu, Concetta Irace, Emma G Wilmot, et al.
Diabetes, Obesity & Metabolism|December 30, 2022
CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative reviewJohn S Pemberton, Emma G Wilmot, Katharine Barnard-Kelly, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 22, 2026
Cost-effectiveness of control-IQ automated insulin delivery in adults with type 1 diabetes in SwedenJohan Jendle, Nuno Picado, Carolina Bulhosa, et al.
Diabetologia|June 11, 2021
Correction to: Acute hyperglycaemia does not have a consistent adverse effect on exercise performance in recreationally active young people with type 1 diabetes: a randomised crossover in-clinic studyKaren M Rothacker, Sam Armstrong, Grant J Smith, et al.
Diabetologia|May 4, 2021
Acute hyperglycaemia does not have a consistent adverse effect on exercise performance in recreationally active young people with type 1 diabetes: a randomised crossover in-clinic studyKaren M Rothacker, Sam Armstrong, Grant J Smith, et al.
Pediatric Diabetes|August 23, 2018
ISPAD Clinical Practice Consensus Guidelines 2018: Exercise in children and adolescents with diabetesPeter Adolfsson, Michael C Riddell, Craig E Taplin, et al.
Diabetologia|December 2, 2023
A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspectiveJohan Jendle, Peter Adolfsson, Pratik Choudhary, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Journal of Diabetes Science and Technology|April 28, 2016
Impact of Type 1 Diabetes Technology on Family Members/Significant Others of People With DiabetesKatharine Barnard, Vincent Crabtree, Peter Adolfsson, et al.
Diabetes Technology & Therapeutics|January 9, 2019
Use of Continuous Glucose Monitoring Trends to Facilitate Exercise in Children with Type 1 DiabetesMarie-Anne Burckhardt, Tarini Chetty, Grant J Smith, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 14, 2025
Insights into the effective use of the Smart MDI system: Data from the first 1852 type 1 diabetes usersAndrea Laurenzi, Shannon N Edd, Peter Adolfsson, et al.
Diabetes, Obesity & Metabolism|December 27, 2024
Minimum expectations for market authorization of continuous glucose monitoring devices in Europe-'eCGM' compliance statusChantal Mathieu, Concetta Irace, Emma G Wilmot, et al.
Diabetes, Obesity & Metabolism|December 30, 2022
CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative reviewJohn S Pemberton, Emma G Wilmot, Katharine Barnard-Kelly, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 22, 2026
Cost-effectiveness of control-IQ automated insulin delivery in adults with type 1 diabetes in SwedenJohan Jendle, Nuno Picado, Carolina Bulhosa, et al.
Diabetologia|June 11, 2021
Correction to: Acute hyperglycaemia does not have a consistent adverse effect on exercise performance in recreationally active young people with type 1 diabetes: a randomised crossover in-clinic studyKaren M Rothacker, Sam Armstrong, Grant J Smith, et al.
Diabetologia|May 4, 2021
Acute hyperglycaemia does not have a consistent adverse effect on exercise performance in recreationally active young people with type 1 diabetes: a randomised crossover in-clinic studyKaren M Rothacker, Sam Armstrong, Grant J Smith, et al.
Pediatric Diabetes|August 23, 2018
ISPAD Clinical Practice Consensus Guidelines 2018: Exercise in children and adolescents with diabetesPeter Adolfsson, Michael C Riddell, Craig E Taplin, et al.
Diabetologia|December 2, 2023
A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspectiveJohan Jendle, Peter Adolfsson, Pratik Choudhary, et al.
Pageof 7